Quick Facts
FONT-SIZE Plus   Neg
Share SHARE

Regis To Dispose Ownership In Provalliance For EUR 80 Mln In Cash - Quick Facts

RELATED NEWS
Trade RGS now with 

Regis Corp. (RGS: Quote) said it agreed with members of the Provost family to sell its minority ownership interest in Provalliance, the largest hair salon company in Europe.

As per the terms of the agreement, Regis will receive 80 million euros in cash. The transaction is expected to close prior to September 30, 2012 and is subject to the Provost family securing financing for the purchase price.

In connection with the agreement, Regis concluded that an after-tax, non-cash net impairment charge, ranging between $15 million and $18 million, related to its investment in Provalliance will be recorded in its third fiscal quarter of 2012. Prior to the impairment charge, Regis' net investment in Provalliance was around 92 million euros.

Click here to receive FREE breaking news email alerts for Regis Corp and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Editors Pick
Looking to increase pressure on Congress, the White House released a report on Tuesday warning of the economic costs of delaying action to address climate change. With the August recess looming, House Republican leaders are hopeful they can pass legislation to address the crisis along the U.S.-Mexico border before the end of the week. The House is expected to vote on a bill providing $659 million in funding for the border crisis, well below the $3.7 billion requested by the Obama administration. After moving mostly higher in early trading on Tuesday, stocks have given back ground over the course of the trading session. A negative reaction to news of new European sanctions against Russia contributed to the pullback by the markets.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.